Search Results

Creoptix AG announced the appointment of Line Stigen Raquet as Chief Executive Officer with effect from beginning of January 2020.

Creoptix AG announced that is has raised CHF 8 million in the first closing as part of a Series C financing round.

Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, announced today its collaboration with Adriano Aguzzi, Professor for Neuropathology, University of Zurich, to characterize immunological responses to SARS-CoV-2* such as IgA, IgM and IgG antibodies, which signal whether an individual has been exposed to the Coronavirus.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 13, 2020.

Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

The new version also delivers new functionality for the analysis of kinetic binding assays for small and large molecules, as well as a host of new automation features.